In addition, Kaplan‒Meier survival analyses with a large cohort of liver cancer patients (the TCGA_LIHC dataset) showed that the 5-year overall survival rate of liver cancer patients with low SLC38A4 expression was significantly lower than that of patients with high SLC38A4 expression (data not shown). This evidence concerns the gene SLC38A4 and liver cancer.